Search

James M. Silbermann

Examiner (ID: 13667)

Most Active Art Unit
1111
Art Unit(s)
1105, 1111, 1109
Total Applications
329
Issued Applications
248
Pending Applications
7
Abandoned Applications
74

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 10749694 [patent_doc_number] => 20160095845 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-04-07 [patent_title] => 'COMPOSITION COMPRISING (S)-(-)-BENPROPERINE FOR PREVENTING OR TREATING CANCER' [patent_app_type] => utility [patent_app_number] => 14/876509 [patent_app_country] => US [patent_app_date] => 2015-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7203 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14876509 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/876509
COMPOSITION COMPRISING (S)-(-)-BENPROPERINE FOR PREVENTING OR TREATING CANCER Oct 5, 2015 Abandoned
Array ( [id] => 11625831 [patent_doc_number] => 20170136021 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-05-18 [patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING ENVELOPED VIRUSES' [patent_app_type] => utility [patent_app_number] => 14/873339 [patent_app_country] => US [patent_app_date] => 2015-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 16279 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14873339 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/873339
METHODS AND COMPOSITIONS FOR TREATING ENVELOPED VIRUSES Oct 1, 2015 Abandoned
Array ( [id] => 12157255 [patent_doc_number] => 20180028520 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-02-01 [patent_title] => 'METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS' [patent_app_type] => utility [patent_app_number] => 15/515679 [patent_app_country] => US [patent_app_date] => 2015-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11995 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15515679 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/515679
METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS Sep 28, 2015 Abandoned
Array ( [id] => 12183287 [patent_doc_number] => 20180042223 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-02-15 [patent_title] => 'COMPOSITION COMPRISING A HYDROGEL AND PESTICIDES' [patent_app_type] => utility [patent_app_number] => 15/510729 [patent_app_country] => US [patent_app_date] => 2015-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5408 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15510729 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/510729
COMPOSITION COMPRISING A HYDROGEL AND PESTICIDES Sep 14, 2015 Abandoned
Array ( [id] => 10737238 [patent_doc_number] => 20160083388 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-03-24 [patent_title] => 'NOVEL MODULATORS OF NRF2 AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/825481 [patent_app_country] => US [patent_app_date] => 2015-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 5249 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14825481 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/825481
NOVEL MODULATORS OF NRF2 AND USES THEREOF Aug 12, 2015 Abandoned
Array ( [id] => 11864746 [patent_doc_number] => 20170232030 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-08-17 [patent_title] => 'COMBINATION THERAPY FOR TREATING CANCER' [patent_app_type] => utility [patent_app_number] => 15/503542 [patent_app_country] => US [patent_app_date] => 2015-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 51 [patent_figures_cnt] => 51 [patent_no_of_words] => 59110 [patent_no_of_claims] => 95 [patent_no_of_ind_claims] => 69 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15503542 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/503542
COMBINATION THERAPY FOR TREATING CANCER Aug 11, 2015 Abandoned
Array ( [id] => 12580656 [patent_doc_number] => 20180085381 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-03-29 [patent_title] => Adjunctive Therapy With 25-Hydroxyvitamin D [patent_app_type] => utility [patent_app_number] => 15/502498 [patent_app_country] => US [patent_app_date] => 2015-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16308 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15502498 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/502498
Adjunctive Therapy With 25-Hydroxyvitamin D Aug 5, 2015 Abandoned
Array ( [id] => 10450614 [patent_doc_number] => 20150335629 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-11-26 [patent_title] => 'Methods Of Treating Fragile X Syndrome And Related Disorders' [patent_app_type] => utility [patent_app_number] => 14/819013 [patent_app_country] => US [patent_app_date] => 2015-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 12416 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14819013 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/819013
Methods Of Treating Fragile X Syndrome And Related Disorders Aug 4, 2015 Abandoned
Array ( [id] => 11954773 [patent_doc_number] => 20170258924 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-09-14 [patent_title] => 'Ester of a Phospholipid With Conjugated Linoleic Acid for the Treatment of Psychiatric Disorders With Neuroinflammatory and Neurodegenerative Basis' [patent_app_type] => utility [patent_app_number] => 15/329968 [patent_app_country] => US [patent_app_date] => 2015-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6631 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15329968 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/329968
Ester of a Phospholipid With Conjugated Linoleic Acid for the Treatment of Psychiatric Disorders With Neuroinflammatory and Neurodegenerative Basis Jul 26, 2015 Abandoned
Array ( [id] => 11750285 [patent_doc_number] => 09708286 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-07-18 [patent_title] => 'Ingenol-3-acylates III and ingenol-3-carbamates' [patent_app_type] => utility [patent_app_number] => 14/748925 [patent_app_country] => US [patent_app_date] => 2015-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 49067 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14748925 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/748925
Ingenol-3-acylates III and ingenol-3-carbamates Jun 23, 2015 Issued
Array ( [id] => 11588466 [patent_doc_number] => 20170112877 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-04-27 [patent_title] => 'NON-TOXIC AGENT FOR A BROAD-SPECTRUM, BACTERICIDAL OR BACTERIOSTATIC TREATMENT OF ANTIBIOTIC-RESISTANT BACTERIA IN ANIMALS' [patent_app_type] => utility [patent_app_number] => 15/317616 [patent_app_country] => US [patent_app_date] => 2015-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 25976 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15317616 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/317616
NON-TOXIC AGENT FOR A BROAD-SPECTRUM, BACTERICIDAL OR BACTERIOSTATIC TREATMENT OF ANTIBIOTIC-RESISTANT BACTERIA IN ANIMALS Jun 14, 2015 Abandoned
Array ( [id] => 11567355 [patent_doc_number] => 20170105999 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-04-20 [patent_title] => 'METHOD FOR TREATING DRUG RESISTANT CANCER' [patent_app_type] => utility [patent_app_number] => 15/316079 [patent_app_country] => US [patent_app_date] => 2015-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 6611 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15316079 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/316079
METHOD FOR TREATING DRUG RESISTANT CANCER Jun 1, 2015 Abandoned
Array ( [id] => 10669562 [patent_doc_number] => 20160015707 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-01-21 [patent_title] => 'METHOD OF PROMOTING REMYELINATION' [patent_app_type] => utility [patent_app_number] => 14/723008 [patent_app_country] => US [patent_app_date] => 2015-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 23354 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14723008 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/723008
Method of promoting remyelination May 26, 2015 Issued
Array ( [id] => 10669562 [patent_doc_number] => 20160015707 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-01-21 [patent_title] => 'METHOD OF PROMOTING REMYELINATION' [patent_app_type] => utility [patent_app_number] => 14/723008 [patent_app_country] => US [patent_app_date] => 2015-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 23354 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14723008 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/723008
Method of promoting remyelination May 26, 2015 Issued
Array ( [id] => 11602394 [patent_doc_number] => 20170119694 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-05-04 [patent_title] => 'SKIN CANCER TREATMENT' [patent_app_type] => utility [patent_app_number] => 15/360084 [patent_app_country] => US [patent_app_date] => 2015-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6561 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15360084 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/360084
Skin cancer treatment May 25, 2015 Issued
Array ( [id] => 11742915 [patent_doc_number] => 20170196987 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-07-13 [patent_title] => 'METHODS FOR TREATING MULTIPLE SCLEROSIS' [patent_app_type] => utility [patent_app_number] => 15/313955 [patent_app_country] => US [patent_app_date] => 2015-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 3705 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15313955 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/313955
METHODS FOR TREATING MULTIPLE SCLEROSIS May 20, 2015 Abandoned
Array ( [id] => 11527181 [patent_doc_number] => 20170087159 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-03-30 [patent_title] => 'PLATELET-DERIVED GROWTH FACTOR RECEPTOR MUTATIONS AND COMPOSITIONS AND METHODS RELATING THERETO' [patent_app_type] => utility [patent_app_number] => 15/311582 [patent_app_country] => US [patent_app_date] => 2015-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 22864 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15311582 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/311582
Platelet-derived growth factor receptor mutations and compositions and methods relating thereto May 14, 2015 Issued
Array ( [id] => 10489818 [patent_doc_number] => 20150374839 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-12-31 [patent_title] => 'NOVEL FATTY ACID-SALICYLATE CONJUGATES WITH ENHANCED THERAPEUTIC PROPERTIES' [patent_app_type] => utility [patent_app_number] => 14/692918 [patent_app_country] => US [patent_app_date] => 2015-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 6718 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14692918 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/692918
NOVEL FATTY ACID-SALICYLATE CONJUGATES WITH ENHANCED THERAPEUTIC PROPERTIES Apr 21, 2015 Abandoned
Array ( [id] => 11441865 [patent_doc_number] => 20170042887 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-02-16 [patent_title] => 'Combination of Brexpiprazole and Nalmefene and Use Thereof for Treating Substance-Related Disorders' [patent_app_type] => utility [patent_app_number] => 15/305782 [patent_app_country] => US [patent_app_date] => 2015-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6841 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15305782 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/305782
Combination of Brexpiprazole and Nalmefene and Use Thereof for Treating Substance-Related Disorders Apr 21, 2015 Abandoned
Array ( [id] => 10421049 [patent_doc_number] => 20150306057 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-29 [patent_title] => 'METHOD FOR THE TREATMENT OF SENILE DEMENTIA OF THE ALZHEIMER\'S TYPE' [patent_app_type] => utility [patent_app_number] => 14/674705 [patent_app_country] => US [patent_app_date] => 2015-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 33278 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14674705 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/674705
Method for the treatment of senile dementia of the Alzheimer's type Mar 30, 2015 Issued
Menu